References
- Ginès P, Fernández-Esparrach G, Arroyo V, Rodés J. Pathogenesis of ascites in cirrhosis. Semin Liver Dis. 1997;17(3):175–189
- Guevara M, Ortega R, Ginès P, Rodés J. Pathogenesis of renal vasoconstriction in cirrhosis. In: Ginès P, Arroyo V, Rodés J, Schrier R, eds. Ascites and Renal Dysfunction in Liver Disease [Internet]. Oxford: Blackwell Publishing Ltd.; 2005:327–340
- Wanless IR, Crawford J. Cirrhosis. In: Odze R, Goldblum J, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tree, and Pancreas. Philadelphia, PA: WB Saunders; 2009:1115–1146
- Schrier RW, Niederberger M, Weigert A, Ginès P. Peripheral arterial vasodilatation: Determinant of functional spectrum of cirrhosis. Semin Liver Dis. 1994;14(1):14–22
- Unikowsky B, Wexler MJ, Levy M. Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites. J Clin Invest. 1983;72(5):1594–1604
- Cárdenas A, Bataller R, Arroyo V. Mechanisms of ascites formation. Clin Liver Dis. 2000;4(2):447–465
- Lin J, Denker BM. Azotemia and urinary abnormalities. In: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, eds. Harrison’sTM Principles of Internal Medicine. 18th ed. New York: Mc Graw Hill; 2012:334–340
- Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Int Ascites Club Hepatol Baltim Md. 1996;23(1):164–176
- Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–1655
- Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: An update. Hepatol Baltim Md. 2009;49(6):2087–2107
- Nobili V, Carter-Kent C, Feldstein AE. The role of lifestyle changes in the management of chronic liver disease. BMC Med. 2011;9(1):70
- Clinical Report on Hydro-Peritoneum, based on an analysis of… Am J Med Sci [Internet]. Available at: http://journals.lww.com/amjmedsci/Fulltext/1863/04000/Clinical_Report_on_Hydro_Peritoneum,_based_on_an.2.aspx. Accessed October 28, 2014
- Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure. Lancet. 1956;271(6953):1121–1125
- Choi YJ, Kim JH, Koo JK, et al. Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol. 2014;20(2):185–191
- Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: Problems and pitfalls. Am J Kidney Dis Off J Natl Kidney Found. 2003;41(2):269–278
- Eckardt KU. Renal failure in liver disease. Intensive Care Med. 1999;25(1):5–14
- Ginès A, Escorsell A, Ginès P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993;105(1):229–236
- Betrosian AP, Agarwal B, Douzinas EE. Acute renal dysfunction in liver diseases. World J Gastroenterol. 2007;13(42):5552–5559
- Cárdenas A, Ginès P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis. Hepatol Baltim Md. 2001;34(4 Pt 1):671–676
- Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatol Baltim Md. 1988;8(5):1151–1157
- Mandell M-S. Cardiac evaluation of liver transplant candidates. World J Gastroenterol. 2008;14(22):3445–3451
- Ray G. Trends of chronic liver disease in a tertiary care referral hospital in Eastern India. Indian J Public Health. 2014;58(3):186–194
- Schepke M, Appenrodt B, Heller J, Zielinski J, Sauerbruch T. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: Results of a prospective study. Liver Int Off J Int Assoc Study Liver. 2006;26(7):834–839
- Moreau R, Lebrec D. Review article: Hepatorenal syndrome – Definitions and diagnosis. Aliment Pharmacol Ther. 2004;20(3):24–28
- Mandal L, Mandal SK, Bandyopadhyay D, Datta S. Correlation of portal vein diameter and splenic size with gastro-oesophageal varices in cirrhosis of liver. J Indian Acad Clin Med. 2011;12(4):266–270
- Montoliu S, Ballesté B, Planas R, et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2010;8(7):616–622
- Fisher EM, Brown DK. Hepatorenal syndrome: Beyond liver failure. AACN Adv Crit Care. 2010;21(2):165–186
- Cárdenas A, Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab. 2003;17(4):607–622
- Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: Diagnostic accuracy, clinical features, and outcome in a tertiary care center. Am J Gastroenterol. 2002;97(8):2046–2050
- Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatol Baltim Md. 1994;20(6):1495–1501
- Fasolato S, Angeli P, Dallagnese L, et al. Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features. Hepatology. 2007;45(1):223–229
- Gustot T, Durand F, Lebrec D, Vincent J-L, Moreau R. Severe sepsis in cirrhosis. Hepatol Baltim Md. 2009;50(6):2022–2033
- Jung ES, Lee JS, Kim MH, Kim NH, Kim KA, Moon YS. [Renal dysfunction after spontaneous bacterial peritonitis in cirrhosis: Incidence and risk factors]. Korean J Gastroenterol Taehan Sohwagi Hakhoe Chi. 2006;48(6):401–407
- Wiest R. Splanchnic and systemic vasodilation: The experimental models. J Clin Gastroenterol. 2007;41(3):S272–S287
- Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest. 1999;104(9):1223–1233
- Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403–409
- Wu C-C, Yeung L-K, Tsai W-S, et al. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol. 2006;65(1):28–33
- Thomson SJ, Westlake S, Rahman TM, et al. Chronic liver disease – An increasing problem: A study of hospital admission and mortality rates in England, 1979–2005, with particular reference to alcoholic liver disease. Alcohol Alcohol Oxf Oxfs. 2008;43(4):416–422
- Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. Hepatol Baltim Md. 2005;41(6):1282–1289